InvestorsHub Logo
Followers 0
Posts 138
Boards Moderated 0
Alias Born 06/29/2011

Re: None

Friday, 04/26/2013 11:21:42 AM

Friday, April 26, 2013 11:21:42 AM

Post# of 29254
The real explosion of the stock price (VPRO) would come when Insulin contracts are signed.

Based on prevalence of diabetes here and worldwide , the price tag on an an insulin clone could surpass all the other biosimilar antibodies combined.
After Sanofi, Lilly, and Novo, Viropro would be the first company ever to bioengineer insulin analgues and market them. Even after patent expiration of all Lilly and Novo insulins, no company has been able to clone them.
I wish the company revealed more about its insulin capabilities. They have mentioned only snippets of info about its insulin program. Any one knows more?